Alzheimer's Disease Neuroimaging Initiative is a multisite study that aims to improve clinical trials for the prevention and treatment of Alzheimer's disease. From Wikipedia
Retrospective AI analysis of AMARANTH data revealed a 46% slower decline in slow-progressors treated with lanabecestat, prompting NHS Innovation East England to fund clinical integration.
